ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

CPGJ602 plus mFOLFOX6 as first-line treatment for patients with KRAS/NRAS/BRAF wild-type metastatic colorectal cancer: A randomized phase II study.

Xu, Jianming; Cao, Bangwei; Gu, Kangsheng; Bai, Yuxian; Li, Wei; Zhang, Jingdong; Liu, Caigang; Niu, Zuoxing; Zhang, Liangming; Zhong, Haijun; Luo, Suxia; Zhou, Jian-Wei; Liu, Tianshu; Gu, Yanhong; Lin, Jingguan; Deng, Yanhong; Chen, Chuangqi; Li, Yunfeng; Yang, Xiuli; Li, Bihui复旦大学; 安徽医科大学; 吉林大学; 哈尔滨医科大学; 郑州大学; 中国医科大学; 中山大学; 中国科学院研究生院; 中国科学院; 6; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)2022-6-1
10阅读
引用收藏
分享
相关
加载中…
  • A multicenter, randomized, open-label, phase III study of anlotinib plus CAPEOX versus bevacizumab plus CAPEOX as first-line therapy in patients with RAS/BRAF wild-type metastatic colorectal cancer
    Ding, K.; Liu, Y.; Song, Y.; Xu, D.; Li, J.; Wang, J.; Chen, X.; Lin, R.; Jiang, Y.; Zhang, Y.; Zhang, W.; Cheng, Y.; Wu, X.; Yuan, Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 2022-09-09 To 2022-09-13.
  • Metformin plus lrinotecan in patients with refractory colorectal cancer: a phase 2 clinical trial
    Arinilda Campos, Bragagnoli; Raphael L. C., Araujo; Mauricio Wagner, Ferraz; Lucas Vieira, dos Santos; Kathia Cristina, Abdalla; Fabiana, Comar; Florinda Almeida, Santos; Marco Antonio, Oliveira; José Barreto Campello, Carvalheira; Flávio Mavigner, Cárcano; João Paulo, da Silveira Nogueira LimaBritish Journal of Cancer, 2021, 124(6): 1072-1078.
  • A randomized, open-label, multicenter, phase III study of high-dose vitamin C plus FOLFOX plus /- bevacizumab versus FOLFOX plus /- bevacizumab as first-line treatment in patients with unresectable metastatic colorectal cancer
    Wang, F.; Xiao, J.; Zhang, Y.; Yuan, X.; He, M.; Fang, W.; Zhang, Y.; Wang, W.; Hu, X.; Ma, Z.; Yao, Y.; Zhuang, Z.; Zhou, F.; Ying, J.; Yuan, Y.; Zou, Q.; Guo, Z.; Wu, X.; Jin, Y.; Mai, Z.; Guo, Y.; Xu, R.ESMO 24th World Congress on Gastrointestinal Cancer, Barcelona, SPAIN, 2022-06-29 To 2022.
查看全部 →

会议信息

会议名称
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
会议日期
2022-06-03 至 2022-06-07
论文集名
JOURNAL OF CLINICAL ONCOLOGY
发表日期
2022-06-01
资助标注
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
收录
ISTP · SCIE

作者

  • X

    Xu, Jianming (第一作者)

  • C

    Cao, Bangwei

查看全部 20 位作者收起作者
  • G

    Gu, Kangsheng

  • B

    Bai, Yuxian

  • L

    Li, Wei

  • Z

    Zhang, Jingdong

  • L

    Liu, Caigang

  • N

    Niu, Zuoxing

  • Z

    Zhang, Liangming

  • Z

    Zhong, Haijun

  • L

    Luo, Suxia

  • Z

    Zhou, Jian-Wei

  • L

    Liu, Tianshu

  • G

    Gu, Yanhong

  • L

    Lin, Jingguan

  • D

    Deng, Yanhong

  • C

    Chen, Chuangqi

  • L

    Li, Yunfeng

  • Y

    Yang, Xiuli

  • L

    Li, Bihui

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417